These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16391819)

  • 1. COX-2 induction by heparanase in the progression of breast cancer.
    Imada T; Matsuoka J; Nobuhisa T; Okawa T; Murata T; Tabuchi Y; Shirakawa Y; Ohara N; Gunduz M; Nagatsuka H; Umeoka T; Yamamoto Y; Nakajima M; Tanaka N; Naomoto Y
    Int J Mol Med; 2006 Feb; 17(2):221-8. PubMed ID: 16391819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2.
    Okawa T; Naomoto Y; Nobuhisa T; Takaoka M; Motoki T; Shirakawa Y; Yamatsuji T; Inoue H; Ouchida M; Gunduz M; Nakajima M; Tanaka N
    Clin Cancer Res; 2005 Nov; 11(22):7995-8005. PubMed ID: 16299228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
    Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
    Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
    Oliveira VM; Piato S; Silva MA
    Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer.
    Cohen I; Maly B; Simon I; Meirovitz A; Pikarsky E; Zcharia E; Peretz T; Vlodavsky I; Elkin M
    Clin Cancer Res; 2007 Jul; 13(14):4069-77. PubMed ID: 17634531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of heparanase gene expression by estrogen in breast cancer.
    Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
    Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas.
    Mikami S; Ohashi K; Katsube K; Nemoto T; Nakajima M; Okada Y
    Pathol Int; 2004 Aug; 54(8):556-63. PubMed ID: 15260846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of expression of heparanase to angiogenesis and prognosis of breast cancer].
    Liu ZZ; Zhang HW; Wei B; Cui SD
    Ai Zheng; 2004 Nov; 23(11):1342-5. PubMed ID: 15522187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.
    Maxhimer JB; Pesce CE; Stewart RA; Gattuso P; Prinz RA; Xu X
    J Am Coll Surg; 2005 Mar; 200(3):328-35. PubMed ID: 15737842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue.
    Leo C; Faber S; Hentschel B; Höckel M; Horn LC
    Ann Diagn Pathol; 2006 Dec; 10(6):327-32. PubMed ID: 17126249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
    Ilan N; Elkin M; Vlodavsky I
    Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells.
    Basu GD; Liang WS; Stephan DA; Wegener LT; Conley CR; Pockaj BA; Mukherjee P
    Breast Cancer Res; 2006; 8(6):R69. PubMed ID: 17156488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase, heparin and the coagulation system in cancer progression.
    Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
    Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma.
    Davidson B; Shafat I; Risberg B; Ilan N; Trope' CG; Vlodavsky I; Reich R
    Gynecol Oncol; 2007 Feb; 104(2):311-9. PubMed ID: 17030350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase and cyclooxygenase-2 gene and protein expressions during progression of oral epithelial dysplasia to carcinoma.
    Nagatsuka H; Siar CH; Tsujigiwa H; Naomoto Y; Han PP; Gunduz M; Sugahara T; Sasaki A; Nakajima M
    Ann Diagn Pathol; 2012 Oct; 16(5):354-61. PubMed ID: 22575501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma.
    Rivera RS; Nagatsuka H; Siar CH; Gunduz M; Tsujigiwa H; Han PP; Katase N; Tamamura R; Ng KH; Naomoto Y; Nakajima M; Nagai N
    Oncol Rep; 2008 Mar; 19(3):657-61. PubMed ID: 18288398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer.
    Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):467-74. PubMed ID: 17255267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of cyclooxygenase-2 in breast cancer and ductal carcinoma in situ has no correlation with established prognostic markers.
    Ranger GS; Jewell A; Thomas V; Mokbel K
    J Surg Oncol; 2004 Nov; 88(2):100-3. PubMed ID: 15499599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flow cytometric quantitative analysis of multiple tumor suppressor gene 1 (MTS1) and cyclooxygenase-2 (COX-2) gene expressions in invasive breast cancers and their clinical significance].
    Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY; Bi Y; Liu YS; Zhou ZB
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):515-7. PubMed ID: 17147116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.